Sandbox: malabsorption: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 117: | Line 117: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* [[Colonoscopy]] with [[biopsy]] | * [[Colonoscopy]] with [[biopsy]] | ||
|- | |||
! align="center" style="background:#DCDCDC;" |[[Cystic fibrosis]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Childhood | |||
Adult | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | |||
* [[Digital clubbing]] | |||
* Abnormal [[breathing sounds]] | |||
* [[Cyanosis]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |↓ | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | |||
* Positive [[DNA]] analysis for [[CFTR]] | |||
* Evaluated [[nasal]] transepithelial potential difference (NPD) | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | |||
* [[Diabetes]] | |||
* Recurrent upper and lower [[respiratory tract infections]] | |||
* [[Infertility]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | |||
* Mutations in the [[cystic fibrosis transmembrane conductance regulator]] ([[CFTR]]) protein | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | |||
* Elevated [[Sweat chloride test|sweat chloride]] ≥60 mmol/L | |||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[VIPoma]] | ! align="center" style="background:#DCDCDC;" |[[VIPoma]] | ||
Line 150: | Line 177: | ||
* Elevated [[VIP]] levels | * Elevated [[VIP]] levels | ||
* Followed by imaging | * Followed by imaging | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Zollinger-Ellison syndrome]] | ! align="center" style="background:#DCDCDC;" |[[Zollinger-Ellison syndrome]] |
Revision as of 15:45, 12 November 2017
Abbreviations: WBC: White blood cells; Plt: Platelets, Hgb: Hemoglobin, IgE: Immunoglobulin E, IgA: Immunoglobulin A
Cause | Peak age of onset | History | Physical exam | Lab findings | Additional findings | Cause/Pathogenesis | Gold standard diagnosis | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fever | Abdominal pain | Diarrhea | Weight loss | |||||||||||
Watery | Fatty | WBC | Hgb | Plt | Other lab findings | |||||||||
Whipple's disease | 40-60 | ± | + | + | + | + |
|
↓ | ↓ | ↓/↑ |
| |||
Celiac disease | Childhood
Adult |
- | + | ± | ± | + | - | ↓ | - |
|
|
|
||
Crohns disease | Young adults
(20th) |
+ | + | + | + | + | ↑ | ↓ | ↑ |
|
|
|
| |
Cystic fibrosis | Childhood
Adult |
± | + | - | + | + |
|
- | ↓ | - |
|
|
| |
VIPoma | 30-50 | - | + | + | + | + |
|
- | - | - |
|
|
| |
Zollinger-Ellison syndrome | 20-50 | - | + | + | + | + | - | ↓ | - |
|
| |||
Eosinophilic gastroenteritis | 30th | - | + | + | + | + | ↑ | - | - |
|
|
|
| |
Primary bile acid malabsorption | Childhood Adult | - | + | + | + | + | - | ↓ | - |
|
|
| ||
Abetalipoproteinemia | Infancy
Adult |
- | + | + | + | + | - | - | - |
|
|
|
| |
Microscopic colitis | 50-70 | - | + | + | - | + | - | ↓ | - |
|
|
|
| |
Hyperthyroidism | Any age | ± | + | + | - | + | - | - | - |
|
||||
Lactose intolerance | Any age | - | + | + | - | - | - | - | - |
|
|
| ||
Irritable bowel syndrome | 30-50 | - | ± | ± | ± | - |
|
- | - | - |
|